Vertex Pharmaceuticals Incorporated (VIE:VRTX)
Austria
· Delayed Price · Currency is EUR 324.40
+2.45 (0.76%)
At close: Sep 25, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Other | 771.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Kalydeco | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Kalydeco Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Collaborative and Royalty | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Collaborative and Royalty Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orkambi | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orkambi Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Symdeko / Symkevi | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Symdeko / Symkevi Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Trikafta / Kaftrio | 10.24B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Trikafta / Kaftrio Growth | 8.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Casgevy | 10.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Collaborative and Royalty | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Collaborative and Royalty Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Other Collaborative and Royalty | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Collaborative and Royalty Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Collaborative and Royalty | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Collaborative and Royalty Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Product | 6.68B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Product Growth | 12.27% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Outside of United States Product | 4.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Outside of United States Product Growth | 6.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|